Golden
Endeavour Vision

Endeavour Vision

A venture capital and private equity firm investing in growth-stage medical technology and digital health companies.

All edits

Edits on 23 Feb 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 23 Feb 2020 1:53 am
Edits made to:
Article (+15/-15 characters)

Article

The big trend that everybody is talking about is the combination of digital health into medical devices.The way we consume medicine in 10 years will not be the same. It's going to be driven by the combination of IT, data, Internet with medical devicesmedical devices. That's a huge opportunity; I personally believe it's as big as when the Internet came on in 2000.
Edits on 20 Feb 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 20 Feb 2020 8:00 am
Edits made to:
Article (+20/-20 characters)

Article

Notable investments made by Endeavour Vision include: Nuvaira, Palares Medical, V-Wave, Relievant Medsystems, Vertiflex, Medartis, Symetis, VentureMed Group, EndoStim, Chrono Therapeutics, ReShape LifesciencesReShape Lifesciences, Inofocus Neuromedical, Sophia, PneumRx, CeQur, and Endocart Medical Technologies.

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 20 Feb 2020 7:58 am
Edits made to:
Article (+6/-6 characters)

Article

On March 22, 2016 Endeavour Vision announced raising a venture capital fund with $275 million (€250 million) in funding that will focus on investing in medical technology and digital health companies. The fund was oversubscribed and had an initial funding target of $175 million (€150 million). The firm plans on using the fund to invest between €10 million and €20 million per investment in companies that have received regulatory approval for their products and services in the United States and/or EuropeEurope. The president, managing partner, and co-founder of Endeavour Vision, Damien Tappy made the follow statement regarding why the fund will focus on healthcare technology companies:

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 20 Feb 2020 7:55 am
Edits made to:
Article (+9/-9 characters)

Article

Notable investments made by Endeavour Vision include: Nuvaira, Palares Medical, V-Wave, Relievant Medsystems, VertiflexVertiflex, Medartis, Symetis, VentureMed Group, EndoStim, Chrono Therapeutics, ReShape Lifesciences, Inofocus Neuromedical, Sophia, PneumRx, CeQur, and Endocart Medical Technologies.

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 20 Feb 2020 1:40 am
Edits made to:
Article (+13/-13 characters)

Article

On March 22, 2016 Endeavour Vision announced raising a venture capital fund with $275 million (€250 million) in funding that will focus on investing in medical technology and digital health companies. The fund was oversubscribed and had an initial funding target of $175 million (€150 million). The firm plans on using the fund to invest between €10 million and €20 million per investment in companies that have received regulatory approval for their products and services in the United StatesUnited States and/or Europe. The president, managing partner, and co-founder of Endeavour Vision, Damien Tappy made the follow statement regarding why the fund will focus on healthcare technology companies:

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 20 Feb 2020 1:33 am
Edits made to:
Article (+11/-11 characters)

Article

Endeavour Vision is a venture capital and private equity firm investing in growth-stage medical technology and digital health companies that is headquartered in Geneva, SwitzerlandSwitzerland and was founded in 2000 by Bernard Vogel, Damien Tappy, and Sven Lingjaerde.

Edits on 19 Feb 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 19 Feb 2020 7:24 pm
Edits made to:
Article (+7/-7 characters)

Article

Notable investments made by Endeavour Vision include: Nuvaira, Palares Medical, V-Wave, Relievant Medsystems, Vertiflex, Medartis, Symetis, VentureMed Group, EndoStim, Chrono Therapeutics, ReShape Lifesciences, Inofocus Neuromedical, Sophia, PneumRxPneumRx, CeQur, and Endocart Medical Technologies.

Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 19 Feb 2020 6:43 pm
Edits made to:
Article (+8/-8 characters)

Article

Notable investments made by Endeavour Vision include: Nuvaira, Palares Medical, V-Wave, Relievant Medsystems, Vertiflex, Medartis, Symetis, VentureMed Group, EndoStimEndoStim, Chrono Therapeutics, ReShape Lifesciences, Inofocus Neuromedical, Sophia, PneumRx, CeQur, and Endocart Medical Technologies.

Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 19 Feb 2020 6:28 pm
Edits made to:
Article (+5/-5 characters)

Article

Notable investments made by Endeavour Vision include: Nuvaira, Palares Medical, V-Wave, Relievant Medsystems, Vertiflex, Medartis, Symetis, VentureMed Group, EndoStim, Chrono Therapeutics, ReShape Lifesciences, Inofocus Neuromedical, Sophia, PneumRx, CeQurCeQur, and Endocart Medical Technologies.

Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 19 Feb 2020 5:15 pm
Edits made to:
Article (+20/-20 characters)

Article

Notable investments made by Endeavour Vision include: Nuvaira, Palares Medical, V-Wave, Relievant MedsystemsRelievant Medsystems, Vertiflex, Medartis, Symetis, VentureMed Group, EndoStim, Chrono Therapeutics, ReShape Lifesciences, Inofocus Neuromedical, Sophia, PneumRx, CeQur, and Endocart Medical Technologies.

Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 19 Feb 2020 5:13 pm
Edits made to:
Article (+6/-6 characters)

Article

Endeavour Vision is a venture capital and private equity firm investing in growth-stage medical technology and digital health companies that is headquartered in GenevaGeneva, Switzerland and was founded in 2000 by Bernard Vogel, Damien Tappy, and Sven Lingjaerde.

Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 19 Feb 2020 5:01 pm
Edits made to:
Article (+19/-19 characters)

Article

Notable investments made by Endeavour Vision include: Nuvaira, Palares Medical, V-Wave, Relievant Medsystems, Vertiflex, Medartis, Symetis, VentureMed Group, EndoStim, Chrono TherapeuticsChrono Therapeutics, ReShape Lifesciences, Inofocus Neuromedical, Sophia, PneumRx, CeQur, and Endocart Medical Technologies.

Golden AI"Adding location topic from lookup Geneva, Switzerland"
Golden AI edited on 19 Feb 2020 2:13 pm
Edits made to:
Infobox (+1 properties)

Infobox

Location
Edits on 26 Nov 2019
Dawson Sewell
Dawson Sewell edited on 26 Nov 2019 3:06 pm
Edits made to:
Description (+117 characters)
Article (+1632 characters)
Further reading (+1 rows) (+4 cells) (+199 characters)
Topic thumbnail

Endeavour Vision

A venture capital and private equity firm investing in growth-stage medical technology and digital health companies.

Article

Endeavour Vision is a venture capital and private equity firm investing in growth-stage medical technology and digital health companies that is headquartered in Geneva, Switzerland and was founded in 2000 by Bernard Vogel, Damien Tappy, and Sven Lingjaerde.

Investments

Notable investments made by Endeavour Vision include: Nuvaira, Palares Medical, V-Wave, Relievant Medsystems, Vertiflex, Medartis, Symetis, VentureMed Group, EndoStim, Chrono Therapeutics, ReShape Lifesciences, Inofocus Neuromedical, Sophia, PneumRx, CeQur, and Endocart Medical Technologies.

Investment funds

Venture fund

On March 22, 2016 Endeavour Vision announced raising a venture capital fund with $275 million (€250 million) in funding that will focus on investing in medical technology and digital health companies. The fund was oversubscribed and had an initial funding target of $175 million (€150 million). The firm plans on using the fund to invest between €10 million and €20 million per investment in companies that have received regulatory approval for their products and services in the United States and/or Europe. The president, managing partner, and co-founder of Endeavour Vision, Damien Tappy made the follow statement regarding why the fund will focus on healthcare technology companies:

The big trend that everybody is talking about is the combination of digital health into medical devices.The way we consume medicine in 10 years will not be the same. It's going to be driven by the combination of IT, data, Internet with medical devices. That's a huge opportunity; I personally believe it's as big as when the Internet came on in 2000.

Further reading

Title
Author
Link
Type
Date

Endeavour Vision closes $275M dedicated med tech, digital health fund

Web

March 22, 2016

Edits on 25 Oct 2019
Henry Ogolla"Approved suggestion #679237"
Henry Ogolla approved a suggestion from Golden's AI on 25 Oct 2019 6:31 pm
Edits made to:
Infobox (+1 properties)
Edits on 11 Oct 2019
Neelam Jhaveri
Neelam Jhaveri edited on 11 Oct 2019 11:34 am
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 9 Aug 2019
Neelam Jhaveri
Neelam Jhaveri edited on 9 Aug 2019 6:03 am
Edits on 21 Jun 2019
Golden AI
Golden AI approved a suggestion from Golden's AI on 21 Jun 2019 6:04 pm
Edits made to:
Infobox (+4 properties)
People (+1 rows) (+2 cells) (+20 characters)
Topic thumbnail

Endeavour Vision

A venture capital and private equity firm investing in growth-stage medical technology and digital health companies.

People

Name
Role
Related Golden topics

Katie Ellias

Employee

Infobox

Golden AI"Initial topic creation"
Golden AI created this topic on 21 Jun 2019 6:04 pm
Edits made to:
Topic thumbnail

 Endeavour Vision

A venture capital and private equity firm investing in growth-stage medical technology and digital health companies.

No more activity to show.